Low hematocrit may connote a malnutrition/inflammation syndrome in hemodialysis patients

Dialysis and Transplantation

Volumn 31, Issue 12, 2002, Pages 845-847+878

  Ifudu, Onyekachi ^a   Uribarri, Jaime ^b   Rajwani, Imran ^b   Vlacich, Vera ^c   Reydel, Kathy ^c   Delosreyes, Georgina ^c   Friedman, Eli A ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Nephrology Foundation of Brooklyn   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN; SERUM ALBUMIN;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; COVARIANCE; DIABETES MELLITUS; FEMALE; HEMATOCRIT; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INFLAMMATION; KAPLAN MEIER METHOD; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; NUTRITIONAL STATUS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE;

EID: 0036902795     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Xia H, Ebben J, Ma JZ, Collins AJ. Hematocrit levels and hospitalization risks in hemodialysis patients. J Am Soc Nephrol 1999; 10:1309-1316.
2. Ma JZ, Ebben J, Xia H, Collins AJ. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999; 10:610-619.
3. Moreno F, Sanz-Guajardo D, Lopez-Gomez JM, Jofre R, Valderrabano F, and the Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. J Am Soc Nephrol 2000; 11:335-342.
4. Churchill DN, Muirhead N, Goldstein M, Posen G, Fay W, Beecroft ML, Gorman J, Taylor DW. Effect of recombinant human erythropoietin on hospitalization of hemodialysis patients. Clin Nephrol 1995; 43:184-188.
5. Madore F, Lowrie E, Brugnara C, Lew NL, Lazarus MJ, Bridges K. Owen WF. Anemia in hemodialysis patients: Variables affecting this outcome predictor. J Am Soc Nephrol 1997; 8:1921-1929.
6. Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study. Kidney Int 1999; 56:2311-2312.
7. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with mortality in maintenance hemodialysis patients [abstract]. Am J Kidney Dis 2001; 37:A20.
8. Bergstrom J, Lindholm B, Lacson E Jr, Owen W Jr, Lowrie EG, Glassock RJ, Ikizler TA, Wessels FJ, Moldawer LL, Wanner C. Zimmermann J. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial 2000; 13:163-175.
9. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15:953-960.
10. Ifudu O, Uribarri J, Rajwani I, Vlacich V, Reydel K, Delosreyes G, Friedman EA. Adequacy of dialysis and differenees in hematocrit among dialysis facilities. Am J Kidney Dis 2000; 36:1166-1174.
11. Ifudu O, Uribarri J, Rajwani I, Vlacich V, Reydel K, Delosreyes G, Friedman EA. Gender modulates responsiveness to recombinant erythropoietin. Am J Kidney Dis 2001; 38:518-522.
12. Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Norpoth M, Giovannini L, Palla R, Tetta C. C-reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif 2000; 18:183-190.
13. Riella MC. Malnutrition in dialysis: Malnourishment or uremic inflammatory response? Kidney Int 2000; 57:1211-1232.
14. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998; 54:627-636.
15. Yeun JY. Clinical utility of C-reactive protein measurements. Semin Dial 2000; 13:56-57.
16. Gambino R. C-reactive protein: Undervalued, underutilized. Clin Chem 1997; 43:2017-2018.
17. Ridker PM. C-reactive protein and risks of future myocardial infarction and thrombotic stroke. Eur Heart J 1998; 19:1-3.
18. Barany P, Divino Filho JC, Bergstrom J. High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 1997; 29:565-568.
19. Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999; 33:63-72.
20. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000; 35:469-176.